BABA
Alibaba Group Holding Limited
BABA has lower modeled downside risk, despite its lower overall score.
GCO
Genesco Inc.
GCO has a slight edge over BABA overall, supported by stronger fundamentals and stronger modeled upside.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
GCO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
GCO's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA has the edge over GCO in the historical PE scenario, which offers more potential upside but is not a forecast.
GCO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6x | $23.89 | -33% |
| Fair | 7.3x | $28.93 | -19% |
| Current | 9x | $35.78 | — |
| Forward | 12x | $35.78 | — |
| Expensive | 20x | $78.41 | +119% |
Historical ranges are pointers, not guarantees.
GCO's PE is in its expensive range at 9.0x. On analysts' estimates for next year's earnings, today's price would be 12x.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over GCO on the outlook, with more favorable revenue expectations.
GCO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect GCO's earnings to grow and its profitability to improve, with its revenue holding steady.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA's earnings per share have fallen from their peak: $4.42 over the past year, against $9.27 in mid-2025. Its recent earnings include one-off gains.
GCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.09 | -22% |
| Q3 2026 | $3.96 | +$6.37 |
| Q2 2026 | $1.85 | +$3.38 |
| Q1 2026 | $1.25 | +$2.99 |
| Q4 2025 | -$0.15 | +$2.46 |
| Q3 2025 | -$2.41 | -$2.16 |
| Q2 2025 | -$1.53 | +$0.60 |
| Q1 2025 | -$1.74 | -$0.24 |
| Q4 2024 | -$2.61 | -$1.87 |
GCO has the edge over BABA on earnings, with more consistent year-over-year improvement.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over GCO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over GCO on profitability, with a higher operating margin.
GCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $529.9M | -3% |
| Q2 2026 | $487M | +2.8% |
| Q1 2026 | $799.9M | +7.2% |
| Q4 2025 | $616.2M | +3.3% |
| Q3 2025 | $546M | +4% |
| Q2 2025 | $474M | +3.6% |
| Q1 2025 | $745.9M | +0.9% |
| Q4 2024 | $596.3M | +2.9% |
GCO's revenue grew through 2021 and has held roughly level since: $530M last quarter, down 3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.7% | +3.3 points |
| Q2 2026 | -3.2% | +2.8 points |
| Q1 2026 | 6.4% | +0.2 points |
| Q4 2025 | 1.4% | -0.3 points |
| Q3 2025 | -2.6% | -0.7 points |
| Q2 2025 | -5.9% | +1.1 points |
| Q1 2025 | 6.2% | +1.1 points |
| Q4 2024 | 1.7% | -0.2 points |
GCO's operating margin was 0.7% last quarter, up 3.3 points from the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
GCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60M | -16% |
| Q2 2026 | -$118.2M | +$1.7M |
| Q1 2026 | $163.5M | +58% |
| Q4 2025 | -$31.5M | +$4.7M |
| Q3 2025 | $71.7M | +262% |
| Q2 2025 | -$119.9M | -$79.8M |
| Q1 2025 | $103.3M | -4.2% |
| Q4 2024 | -$36.2M | -$23.4M |
GCO has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
GCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.4x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | -1.4x | Net Cash |
| Q4 2025 | 1.0x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | 1.1x | Healthy |
GCO has the edge over BABA on leverage, with a lower net debt burden relative to earnings.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
GCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.6 | Neutral |
| Stochastic | 52.5 | Neutral |
GCO's weekly RSI is 52 (neutral) and its Stochastic is 53 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
GCO PE vs Consumer Cyclical Sector
| Metric | GCO | Sector median | Relative |
|---|---|---|---|
| PE | 9x | 18x | 50% below |
| PE % | 68 | 47 | 21 pts above |
GCO has the edge over BABA on valuation relative to its sector.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
GCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.2 | 1.1% below |
| 20 week MA | $35.6 | 0.4% above |
| 50 week MA | $32.9 | 8.9% above |
| 100 week MA | $30.9 | 16% above |
| 200 week MA | $30.6 | 17% above |
GCO has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
GCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.2 | $27.9 | -42% |
| 2021 | $27.9 | $59.8 | +114% |
| 2022 | $59.8 | $44.2 | -26% |
| 2023 | $44.2 | $35.2 | -20% |
| 2024 | $35.2 | $42.1 | +20% |
| 2025 | $42.1 | $25.6 | -39% |
| 2026 YTD | $25.6 | $35.8 | +40% |
GCO has the edge over BABA on returns for 2026, with the stronger performance.